Dsk Medici Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 05-01-2025
- Paid Up Capital ₹ 7.00 M
as on 05-01-2025
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.14 Cr
as on 05-01-2025
- Revenue 10.71%
(FY 2021)
- Profit 37.95%
(FY 2021)
- Ebitda 69.86%
(FY 2021)
- Net Worth 33.37%
(FY 2021)
- Total Assets 28.91%
(FY 2021)
About Dsk Medici
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 7.00 M.
The company currently has active open charges totaling ₹1.14 Cr.
The Key Managerial Personnel (KMP) at Dsk Medici Private Limited India is Nathiya as CEO. Pranavkumar Visakan, Vishakan Kumarasamy, and Anuradha Kunnavakkam serve as directors at the Company.
- CIN/LLPIN
U85110TZ1995PTC006034
- Company No.
006034
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dsk Medici?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranavkumar Visakan  | Managing Director | 11-May-2006 | Current |
| Nathiya | CEO | 01-Dec-2017 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishakan Kumarasamy | Director | 17-Nov-2000 | Current |
| Anuradha Kunnavakkam | Director | 20-Jun-1995 | Current |
Financial Performance of Dsk Medici.
Dsk Medici Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 10.71% increase. The company also saw a substantial improvement in profitability, with a 37.95% increase in profit. The company's net worth Soared by an impressive increase of 33.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dsk Medici?
In 2021, Dsk Medici had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ge Capital Services India Creation Date: 13 Jun 2008 | ₹0.68 M | Open |
Icici Bank Ltd Creation Date: 19 Aug 2005 | ₹0.72 M | Open |
Icici Bank Ltd Creation Date: 04 Apr 2005 | ₹2.23 M | Open |
How Many Employees Work at Dsk Medici?
Dsk Medici has a workforce of 16 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dsk Medici, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dsk Medici's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
